Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E de Boer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Developments in Biological Standardization|January 1, 1975
Evaluation of different techniques for the demonstration of hepatitis B antigen, with special reference to a modified Hepanosticon testH W Ressink, J E de Boer
Biochimica Et Biophysica Acta|June 13, 1980
The halide complexes of myeloperoxidase and the mechanism of the halogenation reactionsA R Bakkenist, J E de Boer, H Plat, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 30, 1976
Transformation of the Hepanosticon test for the detection of HBsAg into a micro-techniqueH W Reerink, J E De Boer, E E Reerink-Brongers
Experimental Cell Research|November 1, 1972
Dose-response of lymphocyte carbohydrate metabolism to phytohaemagglutininD Roos, J E De Boer, L Huismans, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 1, 1990
[Farmacotherapeutisch Kompas 1990-1991]J E de Boer, M Danz, M K Schutte, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 3, 2002
[Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain]A J Croockewit, J E de Boer, J W A van Loenhout, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 1, 1998
[Optimal versus maximal safety of the blood transfusion chain in The Netherlands; results of a conference. College for Blood Transfusion of the Dutch Red Cross]C L van der Poel, J E de Boer, H W Reesink, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 8, 1992
[Farmacotherapeutisch Kompas 1992]J E de Boer, M Danz, M L van Oppenraay, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 5, 1994
[Farmacotherapeutisch Kompas 1994]J E de Boer, M Danz, M L van Oppenraay, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 1993
[Farmacotherapeutisch Kompas 1993]J E de Boer, M Danz, H A van Oppenraay, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Developments in Biological Standardization|January 1, 1975
Evaluation of different techniques for the demonstration of hepatitis B antigen, with special reference to a modified Hepanosticon testH W Ressink, J E de Boer
Biochimica Et Biophysica Acta|June 13, 1980
The halide complexes of myeloperoxidase and the mechanism of the halogenation reactionsA R Bakkenist, J E de Boer, H Plat, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 30, 1976
Transformation of the Hepanosticon test for the detection of HBsAg into a micro-techniqueH W Reerink, J E De Boer, E E Reerink-Brongers
Experimental Cell Research|November 1, 1972
Dose-response of lymphocyte carbohydrate metabolism to phytohaemagglutininD Roos, J E De Boer, L Huismans, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 1, 1990
[Farmacotherapeutisch Kompas 1990-1991]J E de Boer, M Danz, M K Schutte, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 3, 2002
[Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain]A J Croockewit, J E de Boer, J W A van Loenhout, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 1, 1998
[Optimal versus maximal safety of the blood transfusion chain in The Netherlands; results of a conference. College for Blood Transfusion of the Dutch Red Cross]C L van der Poel, J E de Boer, H W Reesink, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 8, 1992
[Farmacotherapeutisch Kompas 1992]J E de Boer, M Danz, M L van Oppenraay, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 5, 1994
[Farmacotherapeutisch Kompas 1994]J E de Boer, M Danz, M L van Oppenraay, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 1993
[Farmacotherapeutisch Kompas 1993]J E de Boer, M Danz, H A van Oppenraay, et al.
Pageof 2